European off-patent industry association Medicines for Europe has announced that Christoph Stoller, Teva’s general manager for Germany and Austria, has taken on the role of president of the association for a two-year term.
He takes over the role from Fresenius Kabi’s Marc-Alexander Mahl, who remains a member of the Medicines for Europe executive...




